Data / Crowdfunding / Maryland / RS BioTherapeutics Inc.
RS BioTherapeutics Inc.: crowdfunding raise on StartEngine Capital, LLC, $10,000 to $1,235,000 (2024)
RS BioTherapeutics Inc., a corporation in Cumberland, MD, filed a Form C with the SEC on May 22, 2024 to raise $10,000 to $1,235,000 in Convertible Note through StartEngine Capital, LLC. The offering closed on July 29, 2024. In its most recent fiscal year it reported $1,778 in revenue and a net loss of $204,030, with 2 employees.
SpecStream is the live web data engine for teams and agents. It reads every Form C on SEC EDGAR each morning, and this page is that reading. Ask for your own cut (a portal, a state, a size, a revenue range) and new raises arrive in your sheet, CRM, Slack or agent as they land.
- Website
- rsbiotherapeutics.com
- Funding portal
- StartEngine Capital, LLC
- Address
- 157 BALTIMORE ST. SUITE 140, Cumberland, MD 21502
- Legal form
- Corporation
- Jurisdiction
- DE
- Incorporated
- February 8, 2021
- SEC CIK
- 0001932193
Offering terms
From the amendment filed May 22, 2024.
- Security
- Convertible Note
- Target
- $10,000
- Maximum
- $1,235,000
- Deadline
- July 29, 2024
- Portal compensation
- 7 - 13 percent
Financials
From the Form C-AR filed September 23, 2026.
| Most recent fiscal year | Prior fiscal year | Source | |
|---|---|---|---|
| Revenue | $1,778 | $0 | sec.gov |
| Cost of goods sold | $0 | $0 | sec.gov |
| Net income | $-204,030 | $-2,204,226 | sec.gov |
| Taxes paid | $2,835 | $0 | sec.gov |
| Total assets | $13,807 | $40,617 | sec.gov |
| Cash | $9,302 | $14,158 | sec.gov |
| Accounts receivable | $0 | $0 | sec.gov |
| Short-term debt | $1,249,122 | $589,895 | sec.gov |
| Long-term debt | $188,555 | $188,555 | sec.gov |
Filings
| Filed | Filing | Target | Maximum | Deadline | Note | Source |
|---|---|---|---|---|---|---|
| September 23, 2026 | Termination of reporting | Not listed | Not listed | sec.gov | ||
| September 23, 2026 | Annual report | Not listed | Not listed | sec.gov | ||
| May 2, 2025 | Annual report | Not listed | Not listed | sec.gov | ||
| September 6, 2024 | Progress update | $10,000 | $1,235,000 | July 29, 2024 | At the close of the offering, the issuer closed on $195,154.48. | sec.gov |
| May 22, 2024 | Amendment | $10,000 | $1,235,000 | July 29, 2024 | Issuer is updating the tagline and elevator pitch on the campaign page. | sec.gov |
| April 29, 2024 | Offering | $10,000 | $1,235,000 | July 29, 2024 | sec.gov |
Also on SpecStream
Updated September 23, 2026. Read from SEC EDGAR. Public domain (U.S. government work). Financials are as each company reported them in its Form C, unaudited unless the filing says otherwise. Websites are the ones the companies declared to the SEC. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.